These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3040767)

  • 41. Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung.
    Nikliński J; Furman M; Palynyczko Z; Laudański J; Bułatowicz J
    Neoplasma; 1991; 38(6):645-51. PubMed ID: 1766488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
    Wertzel H; Grahmann PR; Bansbach S; Lange W; Hasse J; Böhm N
    Eur J Cardiothorac Surg; 1997 Nov; 12(5):698-702. PubMed ID: 9458138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases.
    Gaffey MJ; Mills SE; Lack EE
    Am J Surg Pathol; 1990 Nov; 14(11):1010-23. PubMed ID: 2173427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein.
    DeSanto NG; Veneroso S; Capodicasa G; Crisci A; Giordano C
    Am J Nephrol; 1986; 6(6):458-63. PubMed ID: 2436478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
    Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA
    Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tumor markers for lung neoplasm].
    Sekido Y
    Nihon Rinsho; 2002 May; 60 Suppl 5():229-32. PubMed ID: 12101663
    [No Abstract]   [Full Text] [Related]  

  • 48. CYFRA 21-1 as a tool for distant metastasis detection in lung cancer.
    Cabrera-Alarcon JL; Carrillo-Vico A; Santotoribio JD; Leon-Justel A; Sanchez-Gil R; Gonzalez-Castro A; Guerrero JM
    Clin Lab; 2011; 57(11-12):1011-4. PubMed ID: 22239035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
    Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
    Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan.
    Inoue M; Miyoshi S; Yasumitsu T; Mori T; Iuchi K; Maeda H; Matsuda H
    Ann Thorac Surg; 2000 Nov; 70(5):1615-9. PubMed ID: 11093496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
    Fujii M; Kiura K; Kamei H; Segawa Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):452-5. PubMed ID: 2552209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between CaMBr1 expression and tumor progression in small cell lung carcinomas.
    Martignone S; Bedini AV; Ciavolella A; Ménard S; Patriarca C; Pilotti S; Ravasi G; Tagliabue E; Colnaghi MI
    Tumori; 1989 Aug; 75(4):373-7. PubMed ID: 2554552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carcinoembryonic antigen as differentiation marker for small cell lung cancer in vitro and its clinical relevance.
    Bepler G; Ostholt M; Neumann K; Holle R; Jaques G; Havemann K; Kalbfleisch H
    Anticancer Res; 1989; 9(6):1525-30. PubMed ID: 2483298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epithelial markers of 2 cytokeratin-negative small cell bronchial cancers].
    Bohrer MH; Hastka J
    Pathologe; 1991 Jan; 12(1):21-3. PubMed ID: 1708881
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?
    Nisman B; Lafair J; Heching N; Lyass O; Baras M; Peretz T; Barak V
    Cancer; 1998 May; 82(10):1850-9. PubMed ID: 9587116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
    Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarkers and IL-2R in lung cancer.
    Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL
    Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunohistochemical detection of carcinoembryonic antigen and P-glycoprotein in small cell lung cancer at diagnosis and relapse, with special reference to the tissue expression of CEA and response to chemotherapy].
    Ohnoshi T; Ueoka H; Segawa Y; Kiura K; Tabata M; Shibayama T; Maeda T; Miyatake K; Takigawa N; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Feb; 30(2):262-9. PubMed ID: 1351108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
    Jørgensen LG; Osterlind K; Genollá J; Gomm SA; Hernández JR; Johnson PW; Løber J; Splinter TA; Szturmowicz M
    Br J Cancer; 1996 Aug; 74(3):463-7. PubMed ID: 8695366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.